Everolimus in combination with letrozole inhibit human breast cancer MCF-7/Aro stem cells via PI3K/mTOR pathway: an experimental study

Author： Liu Yan   Zhang Xiaobei   Liu Jingjing   Hou Guofang   Zhang Sheng   Zhang Jin  

Publisher： Springer Publishing Company

ISSN： 1010-4283

Source： Tumor Biology, Vol.35, Iss.2, 2014-02, pp. : 1275-1286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Antitumor effect of the mTOR inhibitor everolimus in combination with trastuzumab on human breast cancer stem cells in vitro and in vivo

By Zhu Yuanxi  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1349-1362

Springer Publishing Company

Access to resources Recommend Favorite

Jolkinolide B induces apoptosis in MCF-7 cells through inhibition of the PI3K/Akt/mTOR signaling pathway

By          

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 212-218

Spandidos Publications

Access to resources Recommend Favorite

Activation of the mTOR signaling pathway in breast cancer MCF7 cells by a peptide derived from Porphyra yezoensis

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 19-24

Spandidos Publications

Access to resources Recommend Favorite

miR125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathway

By          

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 681-686

Spandidos Publications

Access to resources Recommend Favorite

Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines

By  

Molecular Medicine Reports, Vol. 11, Iss. 2, 2015-01 ,pp. : 931-939

Spandidos Publications

Access to resources Recommend Favorite